kanamycin a has been researched along with Tuberculosis, Drug-Resistant in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.48) | 18.7374 |
1990's | 3 (2.61) | 18.2507 |
2000's | 17 (14.78) | 29.6817 |
2010's | 68 (59.13) | 24.3611 |
2020's | 23 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D | 1 |
Chen, S; Ding, CZ; Franzblau, SG; Guo, F; Huang, Z; Li, L; Li, Y; Luo, W; Shen, L; Tang, D; Wang, B; Xu, D; Yang, M; Zhu, Y | 1 |
Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y | 1 |
Barilar, I; Cirillo, DM; Farhat, MR; Freschi, L; Köser, CU; Miotto, P; Niemann, S; Spitaleri, A; Tahseen, S; Vargas, R | 1 |
Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L | 1 |
Ahmed, S; Banu, S; Khatun, R; Nasrin, R; Rahman, A; Rahman, MM; Rahman, SMM; Uddin, MKM | 1 |
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Gui, X; Sun, W; Wu, Z; Yan, L; Zhang, Y | 1 |
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN | 1 |
Doustdar, F; Eslami, G; Ghalavand, Z; Habibnia, S; Karami-Zarandi, M; Kazemian, H; Zaker, S | 1 |
Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR | 1 |
Dou, X; Lu, J; Pan, Y; Yi, Y; Yu, Y; Zhou, L | 1 |
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
Garneau-Tsodikova, S; Green, KD; Hou, C; Punetha, A; Tsodikov, OV | 1 |
Gebreyes, W; Gelaw, B; Robinson, R; Shibabaw, A; Tessema, B; Wang, SH | 1 |
Balkissou Adamou, D; Kuaban, C; Pefura-Yone, EW; Poka-Mayap, V | 1 |
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H | 1 |
Chaiprasert, A; Chongsuvivatwong, V; Faksri, K; Kaewprasert, O; Kusumawati, RL; Pratama, WA; Regmi, SM; Rukmana, A; Sudarmono, P; Tania, T | 1 |
Affolabi, D; de Jong, BC; Decroo, T; Dusabe, T; Habimana, YM; Migambi, P; Mulders, W; Ngabonziza, JCS; Niyigena, EB; Rigouts, L; Supply, P; Ushizimpumu, B; Van Deun, A | 1 |
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
Jain, AK; Sharma, P | 1 |
Achar, J; Azamat, I; Bayram, H; Gil, H; Gomez, D; Margaryan, H; Nazirov, P; Parpieva, N; Singh, J; Zayniddin, S; Ziba, B | 1 |
Ji, Y; Li, Z; Liu, Q; Martinez, L; Qiu, B; Song, H; Wang, J; Yang, D | 1 |
Khoza-Shangase, K; Prodromos, M | 1 |
Barry, CE; Carter, CL; Dartois, V; Ernest, JP; Gengenbacher, M; Kaya, F; Sarathy, J; Savic, RM; Strydom, N; Via, LE; Wang, H; Wang, N; Xie, M; Zimmerman, MD | 1 |
Das, SC; Doyle, C; Momin, MAM; Sinha, S; Tucker, IG | 1 |
Bablishvili, N; Blumberg, HM; Gandhi, NR; Kempker, RR; Mathema, B; Shashkina, E; Tukvadze, N | 1 |
Cao, G; Chen, X; Dai, J; Fu, ZF; Habib, Z; Jamal, M; Rehman, K; Xu, W | 1 |
Aono, A; Chikamatsu, K; Igarashi, Y; Mitarai, S; Takaki, A; Yamada, H; Yi, L | 1 |
Chen, Y; Liang, YP; Liu, HC; Wan, KL; Xia, Q; Xiao, TY; Zeng, CY; Zhao, LL; Zhao, XQ | 1 |
Andres, S; Beckert, P; Heyckendorf, J; Hillemann, D; Kohl, TA; Köser, CU; Lange, C; Merker, M; Moradigaravand, D; Niemann, S; Olaru, ID; Parkhill, J; Peacock, SJ; Schleusener, V; Schön, T; Sturegård, E | 1 |
Leufkens, HGM; Mantel-Teeuwisse, AK; Mavhunga, F; Mekonen, TT; Mengistu, A; Rennie, T; Ruswa, N; Sagwa, EL | 1 |
Ahmed, S; Akhanda, MW; Banu, S; Ebers, A; Gleason, AT; Heysell, SK; Houpt, ER; Rahman, MT | 1 |
Bourkadi, JE; Chaoui, I; Chetioui, F; El Mzibri, M; Elmessaoudi, MD; Karimi, H; Laglaoui, A; Oudghiri, A; Zakham, F | 1 |
Behera, D; Kaur, P; Saini, A; Sethi, S; Yadav, R | 1 |
Ihm, C; Kim, K; Park, J; Park, K; Shin, S; Shin, SY | 1 |
Abdelghani, N; Dawood, H; Naidoo, K; Naidu, N; Padayatchi, N; Perumal, R; Singh, N; Yende-Zuma, N | 1 |
Chhabra, M; Jangra, MS | 1 |
Chirehwa, MT; Court, RG; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L | 1 |
Chaiprasert, A; Phunpruch, S; Prammananan, T; Sowajassatakul, A | 1 |
Govindaswamy, A; Jeyaseelan, L; Michael, JS; Pai, R; Sakthi, D | 1 |
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M | 1 |
Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM | 1 |
Bastard, M; DuCros, P; Galindo, MA; Mahinça, I; Molfino, L; Mutaquiha, C; Rusch, B; Telnov, A; Vaz, D; Zindoga, P | 1 |
Amukoye, E; Nonoh, J; Nyamache, AK; Ogari, CO | 1 |
Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M | 1 |
Bisht, D; Faheem, M; Joshi, B; Khan, AU; Lata, M; Sharma, D; Shukla, S; Venkatesan, K | 1 |
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G | 1 |
Abdi, H; Arube, P; Dlamini, MG; Joloba, ML; Kamulegeya, R; Kasule, GW; Katabazi, FA; Kateete, DP; Khumalo, D; Kigozi, E; Lukoye, D; Musisi, K; Sebit, SI | 1 |
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
Duarte, R; Gaio, R; Oliveira, O; Villar, M | 1 |
Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S | 1 |
Chen, Y; Li, GL; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Wu, XC; Xia, Q; Zhao, LL; Zhao, XQ | 1 |
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP | 1 |
Apsindzelashvili, R; Bablishvili, N; Blumberg, HM; Kempker, RR; Tukvadze, N | 1 |
Kam, KM; Liu, M; Pang, Y; Wang, Y; Zhang, Z; Zhao, Y | 1 |
Liu, B; Pang, Y; Wang, Y; Zhang, D | 1 |
Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A | 1 |
Aung, KJ; Das, PK; Declercq, E; Hossain, MA; Rieder, HL; Sarker, MR; Van Deun, A | 1 |
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
Campbell, PJ; Posey, JE; Reeves, AZ; Willby, MJ | 1 |
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
Cesur, S; Şimşek, H; Tarhan, G | 1 |
Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A | 1 |
Akkerman, OW; Alffenaar, JW; de Lange, WC; Dijkstra, JA; Kosterink, JG; Proost, JH; van Altena, R; van der Werf, TS | 1 |
Huang, H; Ke, Z; Liu, S; Mao, X; Shi, X; Tang, B; Wang, J | 1 |
Leufkens, HG; Mantel-Teeuwisse, AK; Mavhunga, F; Rennie, T; Ruswa, N; Sagwa, EL | 1 |
Anand, S; Gupta, P; Jain, A; Kaur, A; Kaur, S; Rana, V; Sharma, C; Singh, P; Trivedi, G | 1 |
Sibbald, B | 1 |
Ajbani, K; Catanzaro, A; Georghiou, SB; Kambli, P; Nikam, C; Rodrigues, C; Rodwell, TC; Sadani, M; Shetty, A; Udwadia, Z | 1 |
Aubry, A; Brossier, F; Guindo, D; Pham, A; Reibel, F; Sougakoff, W; Veziris, N | 1 |
Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Rodrigues, C; Rodwell, TC; Seifert, M; Valafar, F; Victor, TC | 1 |
Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y | 1 |
Dixit, P; Jain, A; Jaiswal, I; Singh, M; Singh, P; Singhal, P | 1 |
Hosmane, GB; Jain, A; Kushwaha, RA; Prasad, R; Singh, A; Srivastava, R | 1 |
Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS | 1 |
Karak, A; Mukhopadhay, S; Paul, R; Santra, G | 1 |
Aldaba, JG; Ama, CG; Geraldino, XD; Lopez, AL; Salonga, AM; Sarol, JN; Sylim, PG | 1 |
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA | 1 |
Aubry, A; Bernard, C; Brossier, F; Jarlier, V; Pham, A; Sougakoff, W; Veziris, N | 1 |
Li, C; Sugawara, I; Zhang, J | 1 |
Chadha, S; Chandrasekar, V; Chauhan, LS; Dave, PV; Dewan, P; Nalini, S; Narayanan, PR; Paramasivan, CN; Parmar, M; Ramachandran, R; Sahu, S; Sanghvi, AS; Wares, F | 1 |
Bzekalava, N; de Rijk, P; Fissette, K; Jugheli, L; Portaels, F; Rigouts, L | 1 |
Metchock, B; Posey, JE; Shinnick, TM; Sikes, RD; Zaunbrecher, MA | 1 |
Desai, VB; Fredrick, JS; Joseph, P; Mohan, NS; Ramachandran, R; Raman, B; Thomas, A; Wares, F | 1 |
Baba, K; Ehlers, MM; Hoosen, AA; Ismail, NA; Kock, MM; Omar, SV; Osman, AG; Said, HM | 1 |
de Rijk, P; Fissette, K; Martin, A; Palomino, JC; Ramos, E | 1 |
Li, HM; Liang, JQ; Liu, CH; Wang, Q; Yang, N; Yu, HT | 1 |
Catanzaro, A; Catanzaro, DG; Garfein, RS; Georghiou, SB; Magana, M; Rodwell, TC | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Baba, K; Ehlers, MM; Hoosen, AA; Ismail, NA; Kock, MM; Mphahlele, M; Omar, SV; Osman, AG; Said, HM | 1 |
Kumar, V; Lakshmi, R; Rahman, F; Ramachandran, R | 1 |
Dixit, P; Jain, A; Prasad, R | 1 |
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B | 1 |
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
SHIGEMATSU, T | 1 |
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
ALLISON, RF; INGLIS, RM; SCHLESS, JM; TOPPERMAN, S; WHITE, EF | 1 |
Novozhylova, IO | 1 |
Kondakova, MN; Pavlova, MV; Sapozhnikova, NV; Skvortsova, LA | 1 |
Han, L; Lee, DH; Lee, WC; Mitnick, CD; Park, SK; Seung, KJ | 1 |
Belianin, II; Shmelev, EI | 2 |
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V | 1 |
Ovsiankina, ES; Panova, LV | 1 |
Dediste, A; Portaels, F; Rigouts, L; Shamputa, IC; Struelens, M; Umubyeyi, A | 1 |
Chaisuksuwan, R; Pransujarit, V; Punnotok, J; Riantawan, P | 1 |
Pei, X; Yang, Y; Ye, Z | 1 |
Chan, CY; Chau, CH; Cheng, AF; Cheung, SW; Leung, CK; Wong, CF; Yew, WW | 1 |
Naumov, VN; Shaĭkhaev, AIa | 1 |
Kohno, S; Oka, M; Sohda, H; Tsurutani, J | 1 |
Arora, VK; Gupta, R; Gupta, S; Singla, R | 1 |
de Jager, P; van Altena, R | 1 |
5 review(s) available for kanamycin a and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis.
Topics: Animals; Antitubercular Agents; Humans; Kanamycin; Mycobacterium tuberculosis; Rabbits; Randomized Controlled Trials as Topic; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2021 |
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotyping Techniques; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
The safety and tolerability of the second-line injectable antituberculosis drugs in children.
Topics: Adult; Amikacin; Animals; Antitubercular Agents; Capreomycin; Child; Drug Monitoring; Humans; Injections; Kanamycin; Risk Factors; Tuberculosis, Multidrug-Resistant | 2016 |
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Methyltransferases; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Tuberculosis, Multidrug-Resistant | 2012 |
6 trial(s) available for kanamycin a and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.
Topics: Adult; Anesthetics, Local; Anti-Bacterial Agents; Cross-Over Studies; Female; HIV Infections; Humans; Injections, Intramuscular; Kanamycin; Lidocaine; Logistic Models; Male; Middle Aged; Pain Measurement; Pain, Procedural; Single-Blind Method; South Africa; Tuberculosis, Multidrug-Resistant | 2018 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.
Topics: Adult; Antibiotics, Antitubercular; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethionamide; Female; Humans; India; Kanamycin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pyrazinamide; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
[Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
Topics: Adult; Aminosalicylic Acid; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Prothionamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy.
Topics: Adult; Amikacin; Antitubercular Agents; Female; Humans; Kanamycin; Male; Middle Aged; Tuberculosis, Multidrug-Resistant | 1999 |
Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Culture Media; Dermatitis, Phototoxic; Drug Therapy, Combination; Ethionamide; Fluoroquinolones; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
104 other study(ies) available for kanamycin a and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.
Topics: Animals; Antitubercular Agents; Long QT Syndrome; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.
Topics: Amikacin; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Epistasis, Genetic; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bangladesh; DNA, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Genotyping Techniques; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2021 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
Topics: Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2022 |
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Iran; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
Topics: Antitubercular Agents; China; Diabetes Mellitus; Drug Resistance; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Tuberculosis, Multidrug-Resistant | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |
Probing the Robustness of Inhibitors of Tuberculosis Aminoglycoside Resistance Enzyme Eis by Mutagenesis.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Binding Sites; Drug Resistance, Bacterial; Enzyme Inhibitors; Kanamycin; Kinetics; Models, Molecular; Mutagenesis; Mutation; Mycobacterium tuberculosis; Protein Conformation; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Cross-Sectional Studies; Ethiopia; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
[Kanamycin-induced ototoxicity during treatment of multidrug-resistant tuberculosis].
Topics: Adult; Aminoglycosides; Antitubercular Agents; Cameroon; Female; Hearing Loss; Humans; Incidence; Kanamycin; Male; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant | 2020 |
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Whole-genome sequencing analysis of multidrug-resistant
Topics: Adult; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Indonesia; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Phenotype; Phylogeny; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2020 |
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Clofazimine; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Rwanda; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Ethionamide induced blue vision (cyanopsia): Case report.
Topics: Aminosalicylic Acid; Antitubercular Agents; Color Vision Defects; Cycloserine; Ethionamide; Female; Humans; Kanamycin; Linezolid; Moxifloxacin; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
Topics: Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uzbekistan | 2021 |
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
Topics: Acetyltransferases; Adult; Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Multivariate Analysis; Mutation; Mutation Rate; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Prospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2021 |
Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin.
Topics: Adolescent; Adult; Diarylquinolines; Hearing; Humans; Kanamycin; Middle Aged; Quality of Life; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult | 2021 |
Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
Topics: Administration, Inhalation; Aerosols; Cell Line, Tumor; Dry Powder Inhalers; Humans; Kanamycin; Particle Size; Powders; Tuberculosis, Multidrug-Resistant | 2017 |
Impact of
Topics: Acetyltransferases; Antitubercular Agents; Bacterial Proteins; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Georgia (Republic); Humans; Kanamycin; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Adaptive gene profiling of Mycobacterium tuberculosis during sub-lethal kanamycin exposure.
Topics: Adaptation, Physiological; Animals; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Multigene Family; Mutation; Mutation Rate; Mycobacterium tuberculosis; Protein Interaction Maps; Real-Time Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Tuberculosis, Multidrug-Resistant; Virulence | 2017 |
Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Seoul; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2017 |
Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in China.
Topics: Antitubercular Agents; Bacteriological Techniques; China; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Ribosomal Proteins; Tuberculosis, Multidrug-Resistant | 2017 |
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Bacterial Typing Techniques; Cohort Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genome, Bacterial; Genotype; Humans; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2018 |
Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Namibia; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh.
Topics: Adult; Aminoglycosides; Antitubercular Agents; Bangladesh; Body Mass Index; Cohort Studies; Female; Hearing Loss; Humans; Kanamycin; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Risk Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Topics: Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Tuberculosis, Multidrug-Resistant | 2018 |
Diagnostic accuracy of GenoType
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; India; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2018 |
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Semiconductors; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2018 |
Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Capreomycin; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kidney; Male; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant | 2018 |
Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report.
Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Hearing Disorders; Humans; India; Kanamycin; Male; Middle Aged; Suicidal Ideation; Tuberculosis, Multidrug-Resistant | 2018 |
Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
Topics: Acetyltransferases; Amikacin; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2018 |
Pyrosequencing: a rapid and effective sequencing method to diagnose drug-resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique.
Topics: Adult; Antitubercular Agents; Diarylquinolines; Drug Administration Routes; Drug Administration Schedule; Drug Substitution; Female; Humans; Injections; Kanamycin; Male; Middle Aged; Mozambique; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gene Frequency; Genotype; Humans; Isoniazid; Kanamycin; Kenya; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Linezolid; Lung; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tissue Distribution; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Role of M.tuberculosis protein Rv2005c in the aminoglycosides resistance.
Topics: Amikacin; Aminoglycosides; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Protein Interaction Maps; Tuberculosis, Multidrug-Resistant | 2019 |
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
Topics: Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Eswatini; Fluoroquinolones; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sequence Analysis, DNA; Somalia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uganda | 2019 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Global Health; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Portugal; Regression Analysis; Retrospective Studies; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; Genotype; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Performance of the MTBDRsl assay in Georgia.
Topics: Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Georgia (Republic); Humans; Kanamycin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Reproducibility of Results; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Workflow | 2014 |
Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Point Mutation; Tuberculosis, Multidrug-Resistant | 2014 |
Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
Topics: Antitubercular Agents; Bacterial Proteins; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2014 |
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bangladesh; Child; Clofazimine; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Kanamycin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.
Topics: Amikacin; Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Topics: Acetamides; Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Ethionamide; Humans; Kanamycin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Reagent Strips; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis.
Topics: Adult; Amikacin; Antitubercular Agents; Biostatistics; Drug Monitoring; Female; Humans; Kanamycin; Male; Models, Statistical; Retrospective Studies; Specimen Handling; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Coinfection; Hearing Loss; Hearing Tests; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Kanamycin; Logistic Models; Middle Aged; Namibia; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant | 2015 |
Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India.
Topics: 5' Untranslated Regions; Acetyltransferases; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Promoter Regions, Genetic; Tuberculosis, Multidrug-Resistant | 2016 |
Drug-resistant tuberculosis plagues India.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Genes, rRNA; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Promoter Regions, Genetic; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2016 |
Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Genotyping Techniques; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2016 |
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
Topics: Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moldova; Mutation; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Topics: Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Cohort Studies; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Gitelman-like Syndrome with Kanamycin Toxicity.
Topics: Adult; Alkalosis; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Hypokalemia; Kanamycin; Moxifloxacin; Muscle Cramp; Potassium; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Surveillance for tuberculosis in a rural community in The Philippines.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Male; Middle Aged; Philippines; Population Surveillance; Prevalence; Prospective Studies; Public Health; Rifampin; Rural Population; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; France; Humans; Kanamycin; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Multidrug-Resistant | 2009 |
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Topics: Antitubercular Agents; Bacteriological Techniques; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Isoniazid; Kanamycin; Male; Microscopy, Fluorescence; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2009 |
High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Georgia (Republic); Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2009 |
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Promoter Regions, Genetic; Transcription, Genetic; Tuberculosis, Multidrug-Resistant | 2009 |
Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Bacterial; RNA, Ribosomal, 16S; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2012 |
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; China; Female; Hospitals; Humans; Kanamycin; Kanamycin Resistance; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Capreomycin; Child; Cluster Analysis; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Typing; Mycobacterium tuberculosis; Ofloxacin; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Consistency of standard laboratory strain Mycobacterium tuberculosis H 37 Rv with ethionamide susceptibility testing.
Topics: Drug Resistance, Microbial; Ethionamide; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Multidrug-Resistant | 2012 |
Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; India; Kanamycin; Kanamycin Resistance; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2012 |
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[THE PROBLEM OF INFECTION WITH DRUG-RESISTANT MICROORGANISMS-TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Japan; Kanamycin; Statistics as Topic; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1963 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Hepatomegaly; Isoniazid; Kanamycin; Liver Function Tests; Pharmacology; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1965 |
[The treatment of streptomycin-resistant pulmonary tuberculosis with kanamycin].
Topics: Anti-Bacterial Agents; Kanamycin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1960 |
[M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Incidence; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Ukraine | 2003 |
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Topics: Adolescent; Anti-Bacterial Agents; Genotype; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Cycloserine; Female; Humans; Kanamycin; Korea; Male; Middle Aged; Ofloxacin; Prothionamide; Pyrazinamide; Retrospective Studies; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ozone; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
Topics: Adolescent; Amikacin; Antitubercular Agents; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Topics: Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rwanda; Tuberculosis, Multidrug-Resistant | 2008 |
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
[A case of multidrug-resistant pulmonary tuberculosis].
Topics: Administration, Inhalation; Adult; Antibiotics, Antitubercular; Female; Humans; Kanamycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Audiometry; Child; Creatinine; Female; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2002 |